{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T21:27:29Z","timestamp":1771104449576,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jdcr.2022.10.003","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T08:10:26Z","timestamp":1665735026000},"page":"51-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccine"],"prefix":"10.1016","volume":"30","author":[{"given":"Farrah","family":"Bakr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Denny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parastoo","family":"Babakinejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"du Peloux Menag\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdcr.2022.10.003_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000512932","article-title":"Skin manifestations associated with COVID-19: current knowledge and future perspectives","volume":"237","author":"Genovese","year":"2021","journal-title":"Dermatology"},{"key":"10.1016\/j.jdcr.2022.10.003_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jocd.14613","article-title":"Cutaneous and Allergic reactions due to COVID-19 vaccinations: a review","volume":"21","author":"Temiz","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2022.10.003_bib3","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1111\/jdv.16387","article-title":"Cutaneous manifestations in COVID-19: a first perspective","volume":"34","author":"Recalcati","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.jdcr.2022.10.003_bib4","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1111\/jdv.17514","article-title":"Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination","volume":"35","author":"Kreuter","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.jdcr.2022.10.003_bib5","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1111\/jdv.17225","article-title":"Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination","volume":"35","author":"Gambichler","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdcr.2022.10.003_bib6","doi-asserted-by":"crossref","first-page":"e15017","DOI":"10.1111\/dth.15017","article-title":"Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine","volume":"34","author":"Niebel","year":"2021","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jdcr.2022.10.003_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/ced.14858","article-title":"Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination","volume":"47","author":"Kreuter","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2022.10.003_bib8","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1111\/jdv.17895","article-title":"SCLE manifestation after mRNA COVID-19 vaccination","volume":"36","author":"Rechtien","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.jdcr.2022.10.003_bib9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/cup.14281","article-title":"Cutaneous lupus-erythematosus-like reaction arising after COVID-19 vaccination","volume":"49","author":"Rose","year":"2022","journal-title":"J Cutan Pathol"},{"issue":"11","key":"10.1016\/j.jdcr.2022.10.003_bib10","doi-asserted-by":"crossref","DOI":"10.5070\/D3271156093","article-title":"New-onset cutaneous lupus erythematosus after the COVID-19 vaccine","volume":"27","author":"Liu","year":"2021","journal-title":"Dermatol Online J"},{"issue":"3","key":"10.1016\/j.jdcr.2022.10.003_bib11","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1111\/jdv.17827","article-title":"Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis","volume":"36","author":"Zengarini","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jdcr.2022.10.003_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/1346-8138.16210","article-title":"Annular plaques mimicking Rowell's syndrome in the course of coronavirus disease 2019 mRNA vaccines: an overlooked phenomenon?","volume":"49","author":"Niebel","year":"2022","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2022.10.003_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.jdcr.2022.10.003_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13075-017-1243-y","article-title":"Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosis","volume":"19","author":"Wither","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.jdcr.2022.10.003_bib17","doi-asserted-by":"crossref","first-page":"e15114","DOI":"10.1111\/dth.15114","article-title":"Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine","volume":"34","author":"Joseph","year":"2021","journal-title":"Dermatologic Therapy"},{"issue":"1","key":"10.1016\/j.jdcr.2022.10.003_bib15","first-page":"e86","article-title":"New-onset vitiligo following COVID-19 disease","volume":"2","author":"Herzum","year":"2022","journal-title":"Ski Heal Dis"},{"issue":"3","key":"10.1016\/j.jdcr.2022.10.003_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/pcmr.12219","article-title":"Type I interferon signature in the initiation of the immune response in vitiligo","volume":"27","author":"Bertolotti","year":"2014","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512622004556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512622004556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:25:04Z","timestamp":1762475104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512622004556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":17,"alternative-id":["S2352512622004556"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2022.10.003","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccine","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2022.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access..","name":"copyright","label":"Copyright"}]}}